Xenleta

Xenleta (Lefamulin) is an intravenous antibiotic used to treat bacterial infections. It belongs to the pleuromutilin class and is prescribed for community-acquired pneumonia. This product is available for intravenous administration in healthcare settings.

Lefamulin is prescribed to treat bacterial infections, particularly community-acquired pneumonia caused by susceptible organisms. It works by inhibiting bacterial protein synthesis, making it effective against certain gram-positive and atypical pathogens. Patients often ask, 'What is Lefamulin used for?' to understand its role in infection management.

As an antibiotic, Lefamulin targets bacterial growth without directly affecting human cells. Common effects include resolution of infection symptoms such as fever and cough. Some patients may experience mild gastrointestinal discomfort during treatment.

Lefamulin should be handled by healthcare professionals in sterile environments. Patients with known allergies to antibiotics should inform their provider before use. Intravenous administration requires proper monitoring for infusion-related reactions.

Lefamulin may interact with medications metabolized by the liver, including certain CYP3A4 substrates. Combining it with other antibiotics or drugs affecting heart rhythm should be discussed with a healthcare provider. Alcohol use during treatment is generally discouraged.